Table 3.
Summary the DVH analysis for the reference and the RapidPlan plans for the cohort of validation patients from the clinic C
| Objective | Reference | RapidPlan | p | |
|---|---|---|---|---|
| PTV | ||||
| Mean [%] | 100 % | 100.0 ± 0.0 | 100.0 ± 0.0 | - |
| D1% [%] | <107 % | 105.0 ± 1.0 | 104.8 ± 0.9 | - |
| V95% [%] | >95 % | 96.5 ± 2.5 | 97.1 ± 1.1 | - |
| St. Dev. [Gy] | <5 % | 2.5 ± 0.8 | 2.4 ± 0.8 | - |
| Left lung | ||||
| Mean [Gy] | <15Gy | 11.4 ± 4.7 | 10.6 ± 4.2 | 0.01 |
| V20Gy [%] | <20 % | 22.4 ± 10.6 | 18.9 ± 7.2 | 0.01 |
| Right lung | ||||
| Mean [Gy] | <15Gy | 12.6 ± 5.5 | 11.9 ± 5.3 | 0.01 |
| V20Gy [%] | <20 % | 24.4 ± 12.3 | 21.7 ± 11.2 | - |
| Heart | ||||
| Mean [Gy] | Minimise | 15.4 ± 15.1 | 11.9 ± 11.9 | 0.06 |
| V30Gy [%] | <30 % | 22.7 ± 25.5 | 16.2 ± 18.7 | 0.02 |
| Spine | ||||
| D1cm3 [Gy] | <45Gy | 43.3 ± 3.8 | 43.1 ± 4.4 | 0.01 |
| Liver | ||||
| Mean | Minimise | 4.9 ± 7.1 | 4.5 ± 6.4 | 0.01 |
| Spleen | ||||
| Mean [Gy] | Minimise | 19.7 ± 4.2 | 13.9 ± 3.5 | - |
| D1% [Gy] | Minimise | 45.5 ± 3.2 | 43.8 ± 4.1 | - |
| Left kidney | ||||
| V15Gy [%] | <35 % | 14.0 ± 16.5 | 11.5 ± 14.3 | - |
| Right kidney | ||||
| V15Gy [%] | <35 % | 3.8 ± 4.6 | 3.7 ± 4.9 | - |
| Stomach | ||||
| D1% [Gy] | Minimise | 60.8 ± 0.6 | 61.5 ± 0.1 | - |
| Small bowel | ||||
| Mean [Gy] | Minimise | 7.7 ± 2.4 | 6.7 ± 2.3 | 0.01 |
| D1% [Gy] | <45Gy | 39.3 ± 7.0 | 38.8 ± 6.9 | - |